Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9346814 FAP inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jurgen Joossens0

Koen Augustyns0

Koen Jansen0

Leen Heirbaut0

Pieter Van Der Veken0

Ingrid De Meester0

Jonathan D Cheng0

Date of Patent

May 24, 2016

0

Patent Application Number

143727980

Date Filed

January 17, 2013

0

Patent Citations Received

US Patent 12115233 Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α)

0

US Patent 11780821 Inhibitors of fibroblast activation protein

US Patent 11858924 N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides

0

US Patent 11890357 Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis

0

US Patent 11938201 Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9346814 FAP inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.